Canbi Pharma Tech Limited
410528-02-8 Palovarotene;Sohonos

410528-02-8 Palovarotene;Sohonos

CAS:410528-02-8
MF:C27H30N2O2
MW:414.54
EINECS:200-258-5
MDL No.:MFCD10565968

Send Inquiry
Description

Properties

Appearance White to Off-White Solid
Melting point:249-252°C
Boiling point:592.3±50.0 °C
Density 1.11
storage temp. Refrigerator
solubility DMSO (Slightly), Ethyl Acetate (Slightly, Heated), Methanol (Slightly, Heated)
pka4.26±0.10
 

Application:

     Palovarotene is an orally available retinoic acid receptor agonist with specific selectivity towards the gamma subtype of RAR. Palovarotene reduces ALK2/SMAD dependent cartilage formation and bone cell differentiation by binding to RAR γ and inhibiting SMAD1/5/8 phosphorylation, thereby reducing downstream signaling pathways of BMP/ALK2 and achieving a reduction in endochondral bone formation.

 

Synonyms:

Palovarotene

410528-02-8

Sohonos

RG-667

RO-3300074

CLM-001

palovaroteno

R-667

IPN-60120

RO3300074

R 667

4-((1E)-2-(5,5,8,8-Tetramethyl-3-(1H-pyrazol-1-ylmethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)ethenyl)benzoic acid

4-[(E)-2-[5,5,8,8-tetramethyl-3-(pyrazol-1-ylmethyl)-6,7-dihydronaphthalen-2-yl]ethenyl]benzoic acid

Benzoic acid, 4-((1E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-(1H-pyrazol-1-ylmethyl)-2-naphthalenyl)ethenyl)-

palovarotenum

4-{(1E)-2-[5,5,8,8-Tetramethyl-3-(1H-pyrazol-1-ylmethyl)-5,6,7,8-tetrahydronaphthalen-2-yl]ethenyl}benzoic acid

Benzoic acid, 4-[(1E)-2-[5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-(1H-pyrazol-1-ylmethyl)-2-naphthalenyl]ethenyl]-

Sohonos 

Palovarotene(R 667)

GTPL8276

 

Hot Tags: 410528-02-8 palovarotene;sohonos, China 410528-02-8 palovarotene;sohonos manufacturers, suppliers, api data sharing, api referral program api integration, api media api integration, api local api integration, api non profit organization api integration, Cinacalcet hydrochloride

Inquiry
goTop

(0/10)

clearall